Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS

May.06
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.

Key Takeaways

  • Altria recorded first-quarter 2026 net revenues of $5.43 billion, up 3.2%.
  • Revenues net of excise taxes were $4.76 billion, up 5.3%.
  • Adjusted diluted EPS was $1.32, up 7.3%.
  • The company reaffirmed full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72.
  • Altria repurchased $280 million of shares and paid $1.8 billion in dividends during the quarter.

2Firsts, May 6, 2026 

 

According to Altria Group’s first-quarter 2026 earnings release, the company recorded net revenues of $5.43 billion, up 3.2% year on year. Revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, while adjusted diluted EPS was $1.32, up 7.3%.

 

Adjusted diluted EPS rose 7.3% in Q1

 

Altria Chief Executive Officer Billy Gifford said the company grew adjusted diluted EPS by 7.3% in the first quarter and returned capital to shareholders through dividends and share repurchases. 

 

The company said adjusted diluted EPS growth was driven by higher adjusted operating companies income and fewer shares outstanding.

 

Full-year earnings guidance was reaffirmed

 

Altria reaffirmed its expectation to deliver 2026 full-year adjusted diluted EPS in a range of $5.56 to $5.72, representing a growth rate of 2.5% to 5.5% from a base of $5.42 in 2025. 

 

The company said that, as a result of strong first-quarter performance, it now expects 2026 adjusted diluted EPS growth to be more balanced between the first and second halves of the year.

 

Guidance includes moderated e-vapor industry growth

 

Altria said its reaffirmed guidance range now contemplates the impact of moderated e-vapor industry growth on combustible and e-vapor product volumes, as well as increased macroeconomic uncertainty facing adult nicotine consumers. 

 

The guidance also contemplates a progressive increase in cigarette import and export activity during the year, planned investments in contract manufacturing capabilities, NJOY ACE not returning to the marketplace in 2026, reinvestment of anticipated cost savings from the Optimize & Accelerate initiative, and planned investments in support of the company’s Vision.

 

Smokeable products revenues net of excise taxes rose 5.2%

 

In the smokeable products segment, net revenues were $4.76 billion, up 2.9%, while revenues net of excise taxes were $4.11 billion, up 5.2%. Reported operating companies income was $2.67 billion, up 8.3%, and adjusted operating companies income was $2.68 billion, up 6.3%. Adjusted operating companies income margin was 65.1%, up 0.7 percentage points.

 

Domestic cigarette shipment volume declined 2.4%

 

Altria’s smokeable products segment reported domestic cigarette shipment volume of 13.87 billion sticks in the first quarter, down 2.4%. Marlboro shipment volume was 11.96 billion sticks, down 7.8%; other premium brands were 601 million sticks, down 11.4%; and discount brands were 1.31 billion sticks, up more than 100%. 

 

When adjusted for trade inventory movements, the company estimated that smokeable products domestic cigarette shipment volume decreased by 4%, while total domestic cigarette industry volume decreased by 5%.

 

Oral tobacco products revenue increased 2.3%

 

In the oral tobacco products segment, net revenues were $669 million, up 2.3%, while revenues net of excise taxes were $647 million, up 2.9%. Reported operating companies income was $435 million, up 0.5%, and adjusted operating companies income was $436 million, up 0.2%. Adjusted operating companies income margin was 67.4%, down 1.8 percentage points.

 

on! shipment volume increased 17.6%

 

The oral tobacco products segment reported domestic shipment volume of 169.9 million cans, down 3.1%. Copenhagen shipment volume was 80.4 million cans, down 10.4%; Skoal was 27.9 million cans, down 11.1%; and on! was 46.2 million cans, up 17.6%. 

 

Altria said the U.S. nicotine pouch category grew to 58.1% of the U.S. oral tobacco category for the six months ended March 31, 2026, up 9.1 percentage points year on year.

 

on! held a 7.8% share of the U.S. oral tobacco category

 

The total U.S. oral tobacco category share for on! nicotine pouches was 7.8%, down 0.8 percentage points from the prior year and up 0.2 points sequentially. on!’s share of the nicotine pouch category was 13.4%, down 4.2 percentage points year on year.

 

Altria repurchased $280 million of shares and paid $1.8 billion in dividends

 

In the first quarter of 2026, Altria repurchased 4.5 million shares at an average price of $62.33 per share, for a total cost of $280 million. 

 

As of March 31, 2026, the company had $720 million remaining under its $2 billion share repurchase program, which expires on December 31, 2026. The company paid $1.8 billion in dividends during the first quarter.

Image Source:Altria 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Spanish Congress Health Committee Approves Motion to Restrict Vape and Nicotine Pouch Sales to Authorized Channels
Spanish Congress Health Committee Approves Motion to Restrict Vape and Nicotine Pouch Sales to Authorized Channels
Spain’s Congress Health Committee has approved a non-binding motion calling for the sale of vapes, nicotine pouches, and related products to be limited to regulated authorized channels, excluding internet sales and non-specialized stores. The motion was introduced by the Socialist Parliamentary Group and approved after a negotiated text with the Popular Party.
Apr.15 by 2FIRSTS.ai
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s Department of Disease Control has warned the public not to believe claims that nicotine pouches are harmless, saying the products contain high levels of nicotine that can enter the bloodstream through the mouth lining and affect the nervous system and brain.
Apr.30 by 2FIRSTS.ai
Imperial Tobacco Canada Responds to Anti-Smoking Groups on Youth Vaping
Imperial Tobacco Canada Responds to Anti-Smoking Groups on Youth Vaping
Imperial Tobacco Canada responded to the April 17 press conference by anti-smoking groups by calling for a more focused, fact-based discussion on youth vaping that targets the illicit market. The company said youth should not be using nicotine products and that it supports strong measures to prevent youth access, but argued that the discussion failed to clearly distinguish between the regulated market and the illicit market that is driving youth access.
Apr.22 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
Azerbaijan Amends Administrative Offenses Code to Penalize E-Cigarette Violations
Azerbaijan Amends Administrative Offenses Code to Penalize E-Cigarette Violations
Azerbaijan has established fines for the import, export, production and sale of e-cigarettes. Under amendments to the Administrative Offenses Code approved by President Ilham Aliyev, using e-cigarettes in places prohibited by the law “On the Restriction of Tobacco Product Use,” including streets and other public areas, will result in a fine of 30 manat.
Mar.16 by 2FIRSTS.ai
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
Philip Morris Japan announced on April 23 at a product briefing that ZYN by IQOS, an oral tobacco pouch previously launched in selected areas, will expand sales in Tokyo. The company said the product will be released progressively from May 11 through IQOS shops, Lawson and other outlets in the city. The launch will include four flavors, each offered in Low and Medium intensity levels, for a total of eight products.
Apr.27 by 2FIRSTS.ai